Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome


Creative Commons License

MEYNIEL C., SPELMAN T., JOKUBAITIS V. G., TROJANO M., IZQUIERDO G., GRAND'MAISON F., ...Daha Fazla

PLOS ONE, cilt.7, sa.6, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

Özet

Objectives: We conducted a prospective study, MSBASIS, to assess factors leading to first treatment discontinuation in patients with a clinically isolated syndrome (CIS) and early relapsing-remitting multiple sclerosis (RRMS).